ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,933Medicare Part D Prescriptions Filled, Including Refills
$334K Total Retail Price of All Prescriptions
328 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 512 260
HYDROCHLOROTHIAZIDE 470 272
OMEPRAZOLE 392 196
METFORMIN HCL 377 204
PRAVASTATIN SODIUM 271 118
CARVEDILOL 256 143
AMLODIPINE BESYLATE 245 150
TRAMADOL HCL 185 78
LOVASTATIN 170 102
GABAPENTIN 169 74
POTASSIUM CHLORIDE 167 134
FUROSEMIDE 165 112
MIRTAZAPINE 157 101
ATENOLOL 146 117
TRAMADOL HCL-ACETAMINOPHEN 142 71
ENALAPRIL MALEATE 129 67
LEVOTHYROXINE SODIUM 123 94
SIMVASTATIN 109 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 22
HYDROCODONE-ACETAMINOPHEN 106 82 S3
METOPROLOL TARTRATE 103 67
WARFARIN SODIUM 101 58
CITALOPRAM HBR 95 71
ACTOS 90 35
FLUTICASONE PROPIONATE 87 45
GLIMEPIRIDE 86 61
CLOPIDOGREL 85 51
PRENATAL PLUS 85 68
PANTOPRAZOLE SODIUM 75 50
CYCLOBENZAPRINE HCL 73 16 R
LYRICA 72 26
METOPROLOL SUCCINATE 68 52
DONEPEZIL HCL 67 67
RANITIDINE HCL 65 36
SERTRALINE HCL 64 37
TRAZODONE HCL 64 38
PROAIR HFA 63 28
ALLOPURINOL 61 27
SINGULAIR 60 47
BYSTOLIC 59 43
PHENYTOIN SODIUM EXTENDED 56 24
KLOR-CON M20 56 26
ALENDRONATE SODIUM 56 29
RISPERIDONE 55 55
LOSARTAN POTASSIUM 53 39
PAROXETINE HCL 53 15
GLIPIZIDE 51 36
LANTUS SOLOSTAR 50 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.